Clinical Trials in the EU/EEA- Focus on CMC Aspects
Clinical trials testing the Benefit/Risk ratio of Investigational Medicinal Products (IMPs) in the European Union/European Economic Area (EU/EEA) are governed currently by Directive 2001/20/EC. This has led to different requirements amongst the Competent Authorities (CAs) and Ethics Committees (ECs) of each concerned MS.
Jilla Boulas, Delphine Decker, Valerie Pimpaneau, Florence Philippoz
2013 – Pharmaceutical Outsourcing